Grace Therapeutics, Inc..
GRCE.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Grace Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare and orphan diseases. The company's pipeline includes gene therapies and other advanced therapeutic modalities targeting genetic disorders with significant unmet medical nee...Show More
Better Health for All
0
Grace Therapeutics focuses on developing therapies for rare and orphan diseases with significant unmet medical needs. Its entire pipeline is dedicated to addressing conditions with limited or no existing treatment options. For example, GTx-104 for aneurysmal subarachnoid hemorrhage (aSAH) demonstrated a 29% relative increase in favorable outcomes and a 19% reduction in hypotension incidents in a Phase 3 study, addressing a condition that has not seen meaningful innovation in nearly 40 years.
1
Other pipeline products, GTx-102 and GTx-101, target diseases with no FDA-approved therapies.
2
There is no evidence of the company generating revenue from products with negative health outcomes.
3
For safety, Phase 3 trial data for GTx-104 showed comparable adverse event rates to oral nimodipine, with no new safety signals identified, and deaths were attributed to the severity of the underlying disease.
4
Phase 1 studies for GTx-102 and GTx-101 reported no serious adverse events.
5
However, GTx-104 has been granted Orphan Drug Designation, providing seven years of marketing exclusivity, and the company believes its patent estate will protect market value beyond this exclusivity, indicating a focus on patent protection rather than flexibility for global health needs.
6
Fair Money & Economic Opportunity
0
Grace Therapeutics, Inc. is a biopharmaceutical company, and its core business lies outside of financial services. The provided articles do not contain any evidence of the company engaging in lending, insurance, moving, or storing money, nor do they mention any financial products or services offered by Grace Therapeutics.
1
Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are scored as 0, indicating they are not applicable to the company's operations.
Fair Pay & Worker Respect
0
No evidence available to assess Grace Therapeutics, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Grace Therapeutics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
10
Grace Therapeutics has a confidential hotline for reporting ethics violations, available 24/7 in multiple languages from over 30 countries, accessible to employees, customers, vendors, and other interested parties.
1
The company also has anti-corruption and conflicts of interest policies, requiring annual ethics training for employees.
2
However, there is no quantitative data available regarding regulatory fines, transparency index scores, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, or third-party verification of ethical claims.
3
Kind to Animals
-20
Grace Therapeutics, Inc. conducts toxicological studies in several animal species as part of preclinical data generation for drug approval.
1
These animal studies must comply with the FDA's Good Laboratory Practice regulations and the U.S. Department of Agriculture's Animal Welfare Act.
2
The U.S. FDA announced in April 2025 it will begin to phase out mandatory animal testing for investigational new drug (IND) applications,
3
indicating that legal mandates still override alternatives for the company's current operations.
No War, No Weapons
0
No evidence available to assess Grace Therapeutics, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No sustainability data is available for Grace Therapeutics, Inc. (GRCE.US) from the provided articles.
1
All sources explicitly state a complete absence of information regarding environmental performance, targets, or initiatives, making it impossible to score any KPIs related to Planet-Friendly Business.
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles to assess Grace Therapeutics, Inc. against any of the Key Performance Indicators for the ethical value 'Respect for Cultures & Communities'. The articles either discuss general topics, job postings for different entities, or corporate financial and governance matters without detailing community engagement, cultural impact, or related initiatives by GRCE.US.
Safe & Smart Tech
0
The provided articles do not contain specific, concrete data points for Grace Therapeutics, Inc. (GRCE.US) related to any of the Safe & Smart Tech KPIs. For almost all KPIs, the articles explicitly state 'No specific data provided' or 'No mention of' for the company regarding data breaches, AI ethics, cybersecurity investment, privacy certifications, encryption, vulnerability management, or other relevant metrics.
1
While one article mentions ongoing SEC compliance, this does not provide evidence for compliance with the *privacy regulations* (e.g., GDPR, CCPA) specifically referenced in the `regulatory_compliance` KPI.
2
Therefore, no KPIs can be scored based on the available evidence.
Zero Waste & Sustainable Products
0
No evidence available to assess Grace Therapeutics, Inc. on Zero Waste & Sustainable Products.